- PDF Free Download

Size: px

Start display at page:

Download ""

Cornelius Webb
6 years ago
Views:

1 Efficient mycosis therapy using the Bicom Optima Dr. rer. nat. Angelika Buff, Naturopath, Moers, Germany Introduction Candida mycoses play an important part in naturopathic practice 1, whether as a therapy block or even as the cause of a whole series of symptoms. If the change in diet necessary for candida therapy takes too long however, patient compliance usually falls rapidly. For this reason I have developed a candida therapy, which reproducibly removes the candida mycosis within therapy sessions over three weeks. This therefore means for the patient a maximum of 17 days for the dietary change. In the second part of the presentation I would like to introduce some case examples, which also show how the Bicom Optima could be used in practice. Candida therapy Over the last 3 years, 439 patients have been treated in my practice using the candida therapy presented here. In 31 patients a recurrence was detected whereby in most cases reasons for the recurrence could be found (see Figs. 1 and 2, detailing statistics correct at January 2010). With the described therapy, the actual candida treatment is limited to a maximum of 3 sessions. Of course existing blocks such as scar interference fields, geopathogenic exposure or exposure to radiation, temporomandibular joint and spine blocks, etc. should be treated beforehand and the eliminating organs supported. If heavy metal exposure is at the root of the candida mycosis, then it is Number of treated candida mycoses including recurrences Candida recurrence 7% Total number of treated cases: 439 With no recurrence 93% Fig. 1: Total number of treated cases 50 th International Congress for Bicom Therapists, 30 April to 2 May 2010 in Fulda, Germany REGUMED Institut für Regulative Medizin Gräfelfing RTI Volume 34 April

2 Recurrences in treated patients [7%] 3% 6% 7% Mercury exposure 16% 39% Taking of antibiotics Untreated allergies Immunosuppressants Viral illness Unknown 29% Fig. 2: Observed recurrences and their causes Recurrences in treated patients sensible to treat these beforehand, otherwise candida recurrence will be inevitable2: Previous mercury exposure must also be taken into account especially in the second and third candida therapy session. With the described therapy it is always necessary to adjust it individually for each patient, which means that each therapy program is tested individually. Therapy efficiency increases greatly if we carry out tests for each patient to see whether a program is needed or not. The individual duration of the respective treatments plays a significant role too, especially of candida elimination or of the medication oscillations applied. Therapy plan 1st Session: a. Basic therapy b. Remove any blocks if need be c. Support the eliminating organs (often the bowel) d. Candida elimination using 971 with maximum program duration as tested (between minutes) e. Oscillating antimycotic medications using 972 with maximum program duration as tested (between minutes). In my practice the input cup contains: Propolis, echinacea, Regazym plus, tea tree oil, Borax D6, nystatin; amphotericin, Tropaeolum major (nasturtium mother tincture). f. Harmonisation if required (if the patient becomes tired, is shivery or if 127 or 128 test positive [input/output empty for both programs]). At the same time enzymes are prescribed for the patient from the point in time of the first candida therapy session. The medication I use most in my practice is Regazym Plus, or alternatively Wobenzym or in children who are still unable to swallow tablets, Casa Sana Caricol. These enzymes greatly activate the macrophages 3 and so prevent the candida fungus re-entering the weakened macrophages 4, 86 REGUMED Institut für Regulative Medizin Gräfelfing RTI Volume 34 April 2010

3 making it easier in turn to excrete them from the body. This means the total duration of treatment is significantly shortened. In patients with coagulation disorders or who have to take coagulation inhibitors, the dosage of the enzymes should be tested precisely or coagulation values closely monitored while the enzymes are taken. Taking antimycotics during therapy has not been necessary based on the experience of my practice. On the one hand, there was no change whatsoever in therapy parameters with or without antimycotics, while on the other hand it is well known that a whole range of candida strains are resistant to antimycotics. 5 Of course this treatment requires a change of diet to fungi-reducing food my patients are allowed to eat fresh pineapple, since the positive effect obtained from the enzymes compensates for the sugar consumed with the fruit. 2nd Session after 7 days: a. Testing for candida stress. If at this point the candida fungus tests negative, i.e. there is no longer any stress present, then the patient can slowly reintroduce a normal diet after another 3 days of abstinence. If candida still tests as a stress, then the dietary change must be observed until the next therapy session. b. Basic therapy c. Block retest and if need be reprocessing d. Support for eliminating organs e. If there was a mercury stress present before the removal of fungi, only now should the candida-mercury complex be treated i.e. 133 (with mercury and candida in the input and a tested duration of normally 3 10 minutes). Next, the mercury released as a result should be eliminated once again, e.g. using 197 with a tested program duration (usually 5 20 minutes). f. Provocation of the candida fungus using 196 (with the tested treatment time, usually between 3 8 minutes) g. Candida elimination using 971 with maximum tested treatment time. h. Oscillation of antimycotic medications using 972 with maximum tested treatment time. i. Harmonisation if necessary (if the patient becomes tired, is shivery or if 127 or 128 test positive) j. If the candida fungus no longer tested at the start of the session, then recolonisation of the intestine with intestinal symbionts can now be started. Here too the optimum composition of the bacteria is tested, e.g. mutaflor, symbioflor, lactobiogen, lactobact etc. This starts on the 4th day after the therapy session and the enzymes must be taken at least until the 3rd day after the session. 3rd Session after a total of 14 days therapy time: a. The candida stress test at this point normally shows that candida fungus stress is no longer present. The patient after 3 days of therapy can now reintroduce a normal diet again, if this has not already been started previously. b. Basic therapy if required c. Possible block retest and reprocessing if required d. Support for eliminating organs e. If there was a mercury stress present before the removal of fungi, only now should the candida-mercury complex be treated i.e. 133 (with mercury and candida in the input and the time as tested, usually 3 10 minutes). Then the mercury which has now been released must be eliminated again, e.g. using 197 with the tested treatment time (usually 5 20 minutes). f. Provocation of the candida fungus using 196 (with the tested treatment time, usually between 3 8 minutes) REGUMED Institut für Regulative Medizin Gräfelfing RTI Volume 34 April

4 g. Candida elimination using 971 with maximum tested treatment time h. Oscillation of antimycotic medications using 972 with maximum tested treatment time i. Harmonisation if necessary (if the patient becomes tired, is shivery or if 127 or 128 test positive) j. Recolonisation of the intestine on the 4th day after therapy with intestinal symbionts. The intestinal symbionts should be taken in a low dose over a period of 4 weeks CASE STUDIES Case 1: Female, aged 38 Recurring bartholinitis, recurring vaginal mycoses. When the patient came to my practice, she already had a long and eventful two-year history behind her. The causative stresses were candida, streptococci and staphylcocci. The candida was treated in two sessions. The bacterial stress required another 5 sessions. From the 2nd week of candida therapy there was a clear improvement in her symptoms. Since the treatment ended, the patient has been completely free of symptoms. Case 2: Female, aged 68 Lactose intolerance for 4 years with classic symptoms. The candida had already been treated once 2 years previously with nystatin and diet. That had brought a slight improvement in her symptoms, but for a brief period only. In this case candida and lactose were tested. There was no central allergy present. After 3 sessions of candida treatment and a four-week build-up of intestinal flora a retest was carried out for lactose. There was no longer any stress present. Products containing lactose are tolerated without any problem. And this was even though no treatment whatsoever was given for the lactose, only the candida colonisation. Case 3: Male, aged 58 Complete loss of the sense of smell for 8 years, with sense of taste still intact but impaired. The causative stresses found were candida, a house dust mite allergy and PCP. The candida was treated in 3 sessions. After just the second candida session, the patient's sense of smell was slowly returning. The house dust mite allergy was treated once and the PCP stress twice. Since that time there has been no further impairment in the patient s sense of smell. Experiences with Bicom Optima Since May 2009 I have been working with the Bicom Optima in my practice. In general I can confirm all the observations described by Dr. Hennecke last year. Patients tolerate treatment very well when using both channels and hyperintensive reactions occur very rarely. The therapy programs in the low deep frequency range have proved to have a very good effect on patients. It was interesting to observe that some patients left virtually no deposits on the hand or foot plate electrodes when receiving therapy in the normal frequency range, yet with the deep low frequency programs they clearly did so. This was reproducible and observable for instance in the basic therapies. It was particularly noticeable here that when testing the optimum program the low deep frequency programs often tested far better than programs in the normal frequency range. So for instance we were able to test a patient with breast cancer during follow-up treatment, and found that her body preferred the deep low frequency programs for breast cancer aftercare (3025.0, ) of the treatment using CTT. 88 REGUMED Institut für Regulative Medizin Gräfelfing RTI Volume 34 April 2010

5 It is commonly observed that after just one program in the deep low frequency range, e.g. for organ support, no further therapy is required for that organ. For example, liver detox , lymph activation , thymus gland activation to name but a few. It has proven very effective for patients in the treatment of radiation exposure using the 2nd channel directly and with the help of substance complexes or appropriate mineral mixtures alongside the basic therapy. We very frequently include Bach emergency drops in the 2nd channel for eliminating scars. Quartz or schorl rock (black tourmaline) have also proved very useful. We have also found the substance complexes saved under 'Goodies' very interesting, especially for our older patients. When helping a 68-year old female patient to quit smoking, who by her own admission had been smoking for over 50 years, we used what was in effect a wellness treatment for her, based on the Build-up for older ladies, Energy Fitness and Fitness for the Nerves programs. Using these programs we were able to clearly reduce the effort involved for the body when detoxing. A 71-year old patient came to my practice with a fractured vertebra caused by osteoporosis, severe pain and in a poor general state of health. After the Fitness and Body build-up programs, which improved her general state of health, we used in parallel to the removal of blockages from the back, the Bone fracture and Bone healing substance complexes. In the deep low frequency range, the pain programs, especially Pain in the Rib Region, proved highly beneficial. The patient said herself she could imagine doing without bioresonance therapy. It is therefore very worthwhile examining the substance complexes of the Optima more closely. Generally, no limits are set for the therapist's ingenuity when using the 2nd channel. In my practice we use both homoeopathic, phytotherapeutic substances, flowers essences, CTT ampoules as well as allopathics in the 2nd channel. However here too individual tests are carried out. The amplitude and time for the 2nd channel are also determined in this way. Another advantage of the Optima is the update option. This means the software can be easily updated. Using the Bicom Optima and its deep low frequency programs provides a broader therapy spectrum with the 2nd channel providing options for both time and therapy optimisation. Overall, I can say after a year of working with the Bicom Optima that its spectrum has clearly widened in terms of what can be achieved for the patient using bioresonance therapy. Initial teething troubles with both software and hardware have been resolved by Regumed. I am happy that I decided on the Optima and so offer my patients even more efficient treatment. REGUMED Institut für Regulative Medizin Gräfelfing RTI Volume 34 April

6 Literature 1 Siegfried Nolting, Mykosen des Verdauungstraktes [Intestinal Tract Mucoses], medi 1994, ISBN Wolfgang Heinzmann, Siegfried Nolting et al., Candida Intestinaltrakt Immunsystem Allergie, Pro Medico 1999, ISBN Ulrich Arndt, Gift für die Pilze [Toxic to Fungi], in: esotera 12/1997, unter 3 Bertold Heinze, Pflanzliche Enzyme: Therapie der Zukunft [Plant Enzymes: Therapy of the Future], Zeitschrift für Naturheilkunde, ISBN R. Hauss, Informationsschrift Escapeverhalten virulenter Hefen in Diagnostik und Therapie [Escape Behaviour of Virulent Yeasts in Diagnostics and Therapy], unter M. Ruska, J. Belakova, Candidiasis Do we need to fight or tolerate the Candida fungus? Folia Microbiol. 2007, 52 L.J. Douglas, Candida biofilm and their role in infection, Trends Microbiol. 2001, 9 5 Joachim Morschhäuser, Pharmazie in unserer Zeit [Pharmacy in our Time], 2003, 32 Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin, mykosen_gegenueber_azol_antimykotika.pdf 90 REGUMED Institut für Regulative Medizin Gräfelfing RTI Volume 34 April 2010

Epilepsy in childhood

Epilepsy in childhood Dr. Sinan Akkurt, Izmir, Turkey Dear colleagues, Dear bioresonance friends, My Bicom bioresonance adventure which started about 5 years ago is very interesting and continues to surprise